Carlyle hires global regulatory affairs head

Carlyle has hired international trade and policy expert David Marchick to provide in-house government affairs, regulatory and strategic advice to its fund managers.

The Carlyle Group has hired international trade and policy expert David Marchick as its first-ever global head of regulatory affairs.

“As transactions get larger and our business expands globally, so does the complexity of the issues,” said David Rubenstein, Carlyle’s co-founder, in a statement. “Actively engaging policymakers and other stakeholders is more critical than ever to our business.”

A partner in the Washington DC office of Covington & Burlington, Marchick has

Actively engaging policymakers … is more critical than ever to our business.

David Rubenstein

previously advised on big-ticket transactions including Carlyle’s recent sale of aviation assets to Dubai Aerospace Industries, Saudi Arabia Basic Industries’ acquisition of GE Plastics and IBM’s sale of its PC division to China’s Lenovo. Before joining Covington & Burlington in 2002, Marchick held various trade positions in the Clinton administration and also helped coordinate efforts to secure passage of NAFTA and the creation of the World Trade Organization.

At Carlyle, Marchick will focus on regulatory and government-related issues pertaining to global private equity, as well as issues for the firm’s portfolio companies, including acquisitions, sales and ongoing operations. He begins the job on 22 October and will report to Carlyle’s co-founders.

Marchick’s appointment comes as Carlyle continues to expand its operations globally, and as private equity is increasingly exposed to public scrutiny.

The announcement of Marchick’s hire comes the same day as the US’ largest healthcare workers union is holding a demonstration outside Carlyle’s Washington DC headquarters to protest the $6.3 billion acquisition of HCR Manor Care, a nursing home chain. The union is urging Carlyle to put patient care above CEO profits amidst concerns of worsening conditions for nursing home residents post-buyout.